|
Technologies Available for Licensing from NIH/FDA
Cholera
| Development of a Plant Derived Recombinant Subunit Vaccine Candidate Against Hepatitis C |
Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis with over 180 million cases worldwide. Development of a vaccine to combat HCV has been difficult. Presently, the virus cannot be grown in tissue culture and there is no vaccine or effective therapy against this virus. This technology relates to the development of an experimental plant-derived subunit vaccine against HCV. A tobamoviral vector was engineered to encode a con... More ...
|
| Vibrio cholerae O139 Conjugate Vaccines |
Cholera remains an important public health problem. Epidemic cholera is caused by two Vibrio cholerae serotypes O1 and O139. The disease is spread through contaminated water. According to information reported to the World Health Organization in 1999, nearly 8,500 people died and another 223,000 were sickened with cholera worldwide. This invention is a polysaccharide-protein conjugate vaccine to prevent and treat infection by Vibrio cholerae O... More ...
|
Technologies Available for Licensing from Non-Profit Institutions
|
